This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Merrill, Joan
| Item Type | Name |
|
Concept
|
Glucocorticoids
|
|
Academic Article
|
Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort.
|
|
Academic Article
|
Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus.
|
|
Academic Article
|
Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach.
|
|
Academic Article
|
Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus.
|
|
Academic Article
|
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-a) in patients with systemic lupus erythematosus (ROSE).
|
|
Academic Article
|
Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus: Results of a Twenty-Four-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase IIb Study.
|
|
Academic Article
|
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
|
|
Academic Article
|
How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index.
|
|
Academic Article
|
Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial.
|
|
Academic Article
|
Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.
|
|
Academic Article
|
Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus.
|
|
Academic Article
|
Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials.
|
|
Academic Article
|
Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials.
|
|
Academic Article
|
Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus.
|